Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The PROGRESS Study: Safety and Efficacy of the Propel Mini and Propel Nova Steroid-Eluting Sinus Implants Following Surgical Opening of the Frontal Sinus for Chronic Sinusitis: A Randomized Blinded Controlled Study

NCT02266810 is registered in ClinicalTrials.gov with Intersect ENT as lead sponsor.

NCT NCT02266810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02266810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The PROGRESS Study: Safety and Efficacy of the Propel Mini and Propel Nova Steroid-Eluting Sinus Implants Following Surgical Opening of the Frontal Sinus for Chronic Sinusitis: A Randomized Blinded Controlled Study
Lead sponsor
Intersect ENT
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2014
Completion date
October 31, 2016
Enrollment
160 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

chronic sinusitis